Premium
Endovascular treatment of the subclavian artery: Stent implantation with or without predilatation
Author(s) -
Amor Max,
EidLidt Guering,
Chati Zukai,
Wilentz James R.
Publication year - 2004
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.20173
Subject(s) - medicine , restenosis , subclavian artery , stent , surgery , embolization , endovascular treatment , radiology , occlusion , aneurysm
The endovascular treatment of subclavian artery (SA) lesions is less invasive than open surgical repair, with a low rate of complications. We report our experience in 89 subclavian obstructive lesions (n = 86) treated with stenting: 76 (85.3%) stenoses and 13 (14.6%) total occlusions. The left side was most frequently involved (83.1%), localized at the prevertebral segment in 91%. Technical success was obtained in 83 (93.3%) cases, 100% in stenotic lesions and 53.8% in total occlusions. There were nine global complications (10.1%): five (5.6%) at site of puncture, two distal embolization (2.2%), and two (2.3%) major events. The long‐term follow‐up was 3.51 ± 1.98 years, during which time 13 (16.8%) restenoses and 2 (2.6%) reocclusions were noted. Subgroup analysis of patients with stenting after predilatation versus direct stenting technique showed in‐hospital complications only in the first group, with a restenosis rate of 28.5% vs. 4.7%, respectively ( P = 0.003). We consider stenting for SA obstructive lesions the first therapeutic option. Cathet Cardiovasc Interv 2004;63:364–370. © 2004 Wiley‐Liss, Inc.